205 related articles for article (PubMed ID: 11598841)
1. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-alpha and diminished interleukin-10 production.
King CL; Malhotra I; Mungai P; Wamachi A; Kioko J; Muchiri E; Ouma JH
J Infect Dis; 2001 Nov; 184(9):1176-82. PubMed ID: 11598841
[TBL] [Abstract][Full Text] [Related]
2. Increased ratio of tumor necrosis factor-alpha to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity.
Wamachi AN; Mayadev JS; Mungai PL; Magak PL; Ouma JH; Magambo JK; Muchiri EM; Koech DK; King CH; King CL
J Infect Dis; 2004 Dec; 190(11):2020-30. PubMed ID: 15529268
[TBL] [Abstract][Full Text] [Related]
3. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for Schistosoma haematobium.
Subramanian AK; Mungai P; Ouma JH; Magak P; King CH; Mahmoud AA; King CL
Am J Trop Med Hyg; 1999 Sep; 61(3):476-81. PubMed ID: 10497994
[TBL] [Abstract][Full Text] [Related]
4. Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections.
Bustinduy AL; Sutherland LJ; Chang-Cojulun A; Malhotra I; DuVall AS; Fairley JK; Mungai PL; Muchiri EM; Mutuku FM; Kitron U; King CH
Am J Trop Med Hyg; 2015 May; 92(5):945-51. PubMed ID: 25758654
[TBL] [Abstract][Full Text] [Related]
5. Urinary cytokines in Schistosoma haematobium-infected schoolchildren from Tana Delta District of Kenya.
Njaanake KH; Simonsen PE; Vennervald BJ; Mukoko DA; Reimert CM; Gachuhi K; Jaoko WG; Estambale BB
BMC Infect Dis; 2014 Sep; 14():501. PubMed ID: 25223302
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection.
Medhat A; Zarzour A; Nafeh M; Shata T; Sweifie Y; Attia M; Helmy A; Shehata M; Zaki S; Mikhail N; Ibrahim S; King C; Strickland GT
Am J Trop Med Hyg; 1997 Jul; 57(1):16-9. PubMed ID: 9242311
[TBL] [Abstract][Full Text] [Related]
7. Assessment of morbidity in Schistosoma haematobium infection: current methods and future tools.
Jyding Vennervald B; Kahama AI; Reimert CM
Acta Trop; 2000 Oct; 77(1):81-9. PubMed ID: 10996123
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity.
Reimert CM; Mshinda HM; Hatz CF; Kombe Y; Nkulila T; Poulsen LK; Christensen NO; Vennervald BJ
Am J Trop Med Hyg; 2000 Jan; 62(1):19-28. PubMed ID: 10761720
[TBL] [Abstract][Full Text] [Related]
9. Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.
Mduluza T; Ndhlovu PD; Midzi N; Scott JT; Mutapi F; Mary C; Couissinier-Paris P; Turner CM; Chandiwana SK; Woolhouse ME; Dessein AJ; Hagan P
Immunol Lett; 2003 Sep; 88(3):249-56. PubMed ID: 12941484
[TBL] [Abstract][Full Text] [Related]
10. Schistosome infection is associated with enhanced whole-blood IL-10 secretion in response to cercarial excretory/secretory products.
Turner JD; Meurs L; Dool P; Bourke CD; Mbow M; Dièye TN; Mboup S; Polman K; Mountford AP
Parasite Immunol; 2013; 35(5-6):147-56. PubMed ID: 23398537
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment.
Medhat A; Shehata M; Bucci K; Mohamed S; Dief AD; Badary S; Galal H; Nafeh M; King CL
J Infect Dis; 1998 Aug; 178(2):512-9. PubMed ID: 9697734
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological assessment of Schistosoma haematobium-induced kidney and bladder pathology in rural Zimbabwe.
Brouwer KC; Ndhlovu PD; Wagatsuma Y; Munatsi A; Shiff CJ
Acta Trop; 2003 Mar; 85(3):339-47. PubMed ID: 12659971
[TBL] [Abstract][Full Text] [Related]
13. Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with age.
Mutapi F; Winborn G; Midzi N; Taylor M; Mduluza T; Maizels RM
BMC Infect Dis; 2007 Nov; 7():139. PubMed ID: 18045464
[TBL] [Abstract][Full Text] [Related]
14. Morbidity markers for Schistosoma haematobium infection.
Vennervald BJ; Reimert CM; Ouma JH; Kilama WL; Deelder AM; Hatz C
Trop Geogr Med; 1994; 46(4 Spec No):239-41. PubMed ID: 7825227
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Schistosoma haematobium soluble egg antigens inducing antibody production and/or T cell proliferation in humans.
Gaafar T; Helmy M; Ismail S; Afifi A; Guirguis N; el Ridi R
J Egypt Soc Parasitol; 1992 Aug; 22(2):441-51. PubMed ID: 1500785
[TBL] [Abstract][Full Text] [Related]
16. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity.
King CL; Medhat A; Malhotra I; Nafeh M; Helmy A; Khaudary J; Ibrahim S; El-Sherbiny M; Zaky S; Stupi RJ; Brustoski K; Shehata M; Shata MT
J Immunol; 1996 Jun; 156(12):4715-21. PubMed ID: 8648117
[TBL] [Abstract][Full Text] [Related]
17. Sonographic early findings in a case of bladder schistosomiasis.
Ferrara D; Esposito F; Di Serafino M; Gullotto C; Baglioni A; Martinelli L; Zeccolini M
J Ultrasound; 2018 Sep; 21(3):259-263. PubMed ID: 30003454
[TBL] [Abstract][Full Text] [Related]
18. Malaria co-infection in children influences antibody response to schistosome antigens and inflammatory markers associated with morbidity.
Remoue F; Diallo TO; Angeli V; Hervé M; de Clercq D; Schacht AM; Charrier N; Capron M; Vercruysse J; Ly A; Capron A; Riveau G
Trans R Soc Trop Med Hyg; 2003; 97(3):361-4. PubMed ID: 15228260
[TBL] [Abstract][Full Text] [Related]
19. Sonographic screening for urinary tract abnormalities in patients with Schistosoma haematobium infection: pitfalls in examining pregnant women.
Richter J; Wagatsuma Y; Aryeetey M; Feldmeier H
Bull World Health Organ; 1996; 74(2):217-21. PubMed ID: 8706238
[TBL] [Abstract][Full Text] [Related]
20. Differential production in vitro of antigen specific IgG1, IgG3 and IgA: a study in Schistosoma haematobium infected individuals.
Béniguel L; Diallo TO; Remoué F; Williams DL; Cognasse F; Charrier-Mze N; N'Diaye AA; Perraut R; Capron M; Riveau G; Garraud O
Parasite Immunol; 2003 Jan; 25(1):39-44. PubMed ID: 12753436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
